| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President And CEO
1 company
Chang David D is a President And CEO at ALLO. Recent filings cover 1 purchase and 6 sales. Those positions are worth an estimated $10.3M at current prices.
Our model assigns Chang David D a middling insider score of 56/100, based on 4 past trades. Over a 12-month horizon, 50.0% of those trades were profitable, with an average 12-month return of +19.9%.
Chang David D's largest disclosed position is in ALLO as President And CEO, worth about $10.3M. The recent filings there lean toward selling, a net 117,167 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 14, 2025 | ALLO Allogene Therapeutics, Inc. | President And CEO | Sell | 46,668 | $1.96 | $91,469.28 | -0.9% | -27.8% | +23.7% | |
| Feb 3, 2025 | ALLO Allogene Therapeutics, Inc. | President And CEO | Sell | 46,003 | $1.68 | $77,285.04 | -0.9% | -3.0% | +4.2% | |
| Mar 15, 2022 | ALLO Allogene Therapeutics, Inc. | President And CEO | Sell | 23,648 | $7.65 | $180,878.82 | -1.0% | +13.5% | -27.4% | |
| Mar 15, 2021 | ALLO Allogene Therapeutics, Inc. | President And CEO | Sell | 20,513 | $38.57 | $791,270.51 | -0.9% | -35.0% | -80.0% | |
| Mar 16, 2020 | ALLO Allogene Therapeutics, Inc. | President And CEO | Sell | 20,335 | $19.31 | $392,615.23 | -0.9% | - | - | |
| Oct 15, 2018 | ALLO Allogene Therapeutics, Inc. | President And CEO | Buy | 40,000 | $18.00 | $720,000.00 | +2.0% | - | - |